腸内フローラとディスバイオーシス（バランス失調）

出版社： 医薬出版
著者：
発行日： 2019-09-20
分野： 基礎医学  >  医動物(寄生虫)
ISBN： 9784990673970
電子書籍版： 2019-09-20 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

5,280 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

3,696 円(税込)

購入する

目次

  • 特別講演１ 「腸内細菌による免疫修飾」

    特別講演２ 「抗菌薬耐性微生物に対する耐性を持つ共生細菌の同定」

    講　　演１ 「ディスバイオーシス、腸内フローラ・脳・腸連関とメンタルヘルス」

    講　　演２ 「腸管外現象に影響を及ぼす特定の乳酸菌」

    講　　演３ 「口腔微生物叢と歯のケアが腸内微生物叢に及ぼす影響」

    講　　演４ 「ヒト腸内フローラの個体レベル研究と臨床研究：
    　　　　　　　定量的フローラモニタリングの必要性」

    講　　演５ 「腸内フローラの dysbiosis と
    　　　　　　　プロバイオティクス・シンバイオティクスの応用」

    総合討論

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

はじめに

P.5 掲載の参考文献
1) 神谷茂 : 腸内フローラと内科疾患. Jpn J Antibiotics, 70 : 1-13, 2017
 
2) Sohail MU, Althani A, Anwar H, Rizzi R, Marei HE : Role of the gastrointestinal tract microbiome in the pathophysiology of Diabetes Mellitus. J Diab Res 9631435, doi : 10.1155/2017/9631435, 2017
 
3) Pietieinen M, Liljestrand JM, Kopra E, Pussinen PJ : Mediators between oral dysbiosis and cardiovascular diseases. Eur J Oral Sci 126 (Suppl. 1) : 26-36 doi : 10.1111/eos.12423
 
4) Pascal M, Perez-Gordo M, Caballero T, Escribese MM, Lopez Longo MN, Luengo O, Manso L, Matheu V, Seoane E, Zamorano M, Labrador M, Mayorga C : Microbiome and allergic diseases. Front Immunol 9 : 1584, doi : 10.3389/fimmu.2018.01584, 2018
 
5) Kim S, Jazwinski SM : The gut microbiota and healthy aging-A mini-review. Gerontology 64 : 513-520, 2018
PubMed
6) Ni J, Wu GD, Albenberg L, Tomov VT : Gut microbiota and IBD : causation or correlation? Nature Rev Gastroenterol Hepatol, 14 : 573-584, 2017
PubMed
7) Zuo T, Wong SH, Cheung CP, Lam K, Lui R, Cheung K, Zhang F, Tang W, Ching JYL, Wu JCY, Chan PKS, Sung JJY, Yu J, Chan FKL, Ng SC : Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in C. difficile infection. Nat Commun 9 : 3663. Doi : 10.1038/s41467-018-06103-6, 2018
 

特別講演1. 腸内細菌による免疫修飾

P.9 掲載の参考文献
1) Mimee, M., Citorik, R. J. & Lu, T. K. Microbiome therapeutics-Advances and challenges. Advanced drug delivery reviews 105, 44-54, doi : 10.1016/j.addr.2016.04.032 (2016).
 
2) Kim, S., Covington, A. & Pamer, E. G. The intestinal microbiota : Antibiotics, colonization resistance, and enteric pathogens. Immunological reviews 279, 90-105, doi : 10.1111/imr.12563 (2017).
 
3) Bhatt, A. P., Redinbo, M. R, & Bultman, S. J. The role of the microbiome in cancer development and therapy. CA : a cancer journal for clinicians 67, 326-344, doi : 10.3322/caac.21398 (2017).
 
4) Honda, K. & Littman, D. R. The microbiota in adaptive immune homeostasis and disease. Nature 535, 75-84, doi : 10.1038/nature18848 (2016).
 
5) El Hage, R., Hernandez-Sanabria, E. & Van de Wiele, T. Emerging Trends in "Smart Probiotics" : Functional Consideration for the Development of Novel Health and Industrial Applications. Frontiers in microbiology 8, 1889, doi : 10.3389/fmicb.2017.01889 (2017).
 
6) O'Toole, P. W., Marchesi, J. R. & Hill, C. Next-generation probiotics : the spectrum from probiotics to live biotherapeutics. Nat Microbiol 2, 17057, doi : 10.1038/nmicrobiol.2017.57 (2017).
 
7) Blander, J. M., Longman, R. S., Iliev, I. D., Sonnenberg, G. F. & Artis, D. Regulation of inflammation by microbiota interactions with the host. Nat Immunol 18, 851-860, doi : 10.1038/ni.3780 (2017).
 
8) Ivanov, II et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498, (2009).
PubMed
9) Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341, (2011).
PubMed
10) Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236, (2013).
PubMed
11) Atarashi, K. et al. Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells. Cell 163, 367-380, (2015).
PubMed
12) Atarashi, K. et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science 358, 359-365, (2017).
PubMed

特別講演2. 抗菌薬耐性微生物に対する耐性を持つ共生細菌の同定

P.13 掲載の参考文献
1) Abt MC, Buffie CG, Susac B, Becattini S, Carter RA, Leiner I, Keith JW, Artis D, Osborne LC, Pamer EG. TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus. Science Translational Medicine. 2016 ; 8 (327) : 327ra25.
PubMed
2) Xiong H, Keith JW, Samilo DW, Carter RA, Leiner IM, Pamer EG. Innate Lymphocyte/Ly6C (hi) Monocyte crosstalk promotes Klebsiella pneumoniae clearance. Cell. 2016 ; 165 (3) : 679-89.
PubMed
3) Caballero S, Kim S, Carter RA, Leiner IM, Susac B, Miller L, Kim GJ, Ling L, Pamer EG. Cooperating commensals restore colonization resistance to vancomycin-resistant Enterococcus faecium. Cell Host Microbe. 2017 ; 21 (5) : 592-602.
PubMed
4) Becattini S, Littmann ER, Carter RA, Kim SG, Morjaria SM, Ling L, Gyaltshen Y, Fontana E, Taur Y, Leiner IM, Pamer EG. Commensal microbes provide first line defense against Listeria monocytogenes infection. Journal of Experimental Medicine. 2017 ; 214 (7) : 1973-1989.
PubMed
5) Lewis BB, Carter RA, Ling L, Leiner I, Taur Y, Kamboj M, Dubberke ER, Xavier J, Pamer EG. Pathogenicity locus, core genome, and accessory gene contributions to Clostridium difficile virulence. MBio. 2017 ; 8 (4). pii : e00885-17.
 
6) Haak BW, Littmann ER, Chaubard JL, Pickard AJ, Fontana E, Adhi F, Gyaltshen Y, Ling L, Morjaria SM, Peled JU, van den Brink MR, Geyer AI, Cross JR, Pamer EG, Taur Y. Impact of gut colonization with butyrate producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018 ; Apr 19. pii : blood-2018-01-828996.
 
7) Taur Y, Coyte K, Schluter J, Gjonbalaj M, Littmann E, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young J, Peled J, Meagher R, Jenq R, van den Brink M, Giralt S, Pamer E, Xavier J. Microbiota-remediation after antibiotic-induced loss of commensal bacteria. Science Translational Medicine 2019. (In Press)
 

講演1. ディスバイオーシス, 腸内フローラ・脳・腸連関とメンタルヘルス

P.22 掲載の参考文献
1) Reber SO, Siebler PH, Donner NC et al. Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice. Proc Natl Acad Sci U S A 2016 ; 113 : E3130-E3139.
PubMed
2) Reber SO, Langgartner D, Foertsch S et al. Chronic subordinate colony housing paradigm : A mouse model for mechanisms of PTSD vulnerability, targeted prevention, and treatment-2016 Curt Richter Award Paper. Psychoneuroendocrinology 2016 ; 74 : 221-230.
 
3) Eraly SA, Nievergelt CM, Maihofer AX et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014 ; 71 : 423-431.
PubMed
4) Langgartner D, Peterlik D, Foertsch S et al. Individual differences in stress vulnerability : The role of gut pathobionts in stress-induced colitis. Brain Behav Immun 2017 ; 64 : 23-32.
PubMed
5) Lowry CA, Smith DG, Siebler PH et al. The microbiota, immunoregulation, and mental health : Implications for public health. Curr Environ Health Rep 2016 ; 3 : 270-286.
PubMed
6) Zuany-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002 ; 8 : 625-629.
PubMed
7) Miller AH, Raison CL. Are anti-inflammatory therapies viable treatments for psychiatric disorders? : Where the rubber meets the road. JAMA Psychiatry 2015 ; 72 : 527-528.
PubMed
8) Miller AH, Raison CL. The role of inflammation in depression : from evolutionary imperative to modern treatment target. Nat Rev Immunol 2016 ; 16 : 22-34.
 
9) Hodes GE, Pfau ML, Leboeuf M et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci U S A 2014 ; 111 : 16136-16141.
PubMed
10) Cryan JF, Dinan TG. Mind-altering microorganisms : the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012 ; 13 : 701-712.
PubMed
11) Cryan JF, Dinan TG. More than a gut feeling : the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacology 2015 ; 40 : 241-242.
PubMed
12) Logan AC, Jacka FN, Craig JM, Prescott SL. The microbiome and mental health : Looking back, moving forward with lessons from allergic diseases. Clin Psychopharmacol Neurosci 2016 ; 14 : 131-147.
PubMed
13) Rook GA, Adams V, Hunt J, Palmer R, Martinelli R, Brunet LR. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol 2004 ; 25 : 237-255.
PubMed
14) Sonnenburg ED, Sonnenburg JL. Starving our microbial self : The deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab 2014 ; 20 : 779-786.
PubMed
15) von Hertzen L, Beutler B, Bienenstock J et al. Helsinki alert of biodiversity and health. Ann Med 2015 ; 47 : 218-225.
PubMed
16) Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans : Ancient history, modern implications. J Clin Invest 2009 ; 119 : 2475-2487.
PubMed
17) Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009 ; 7 : 887-894.
PubMed
18) von Hertzen L, Hanski I, Haahtela T. Natural immunity. Biodiversity loss and inflammatory diseases are two global megatrends that might be related. EMBO Rep 2011 ; 12 : 1089-1093.
PubMed
19) Lowry CA, Smith DG, Siebler PH et al. The microbiota, immunoregulation and mental health : implications for public health. Current Environmental Health Reports 2016 ; 3 : 270-286.
PubMed
20) Langgartner D, Lowry CA, Reber SO. Old friends, immunoregulation, and stress resilience. Pflugers Arch 2019 ; 471 : 237-269.
PubMed
21) Kullberg MC, Ward JM, Gorelick PL et al. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10) -deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998 ; 66 : 5157-5166.
 
22) Guo G, Jia KR, Shi Y et al. Psychological stress enhances the colonization of the stomach by Helicobacter pylori in the BALB/c mouse. Stress 2009 ; 12 : 478-485.
PubMed
23) Pena JA, Rogers AB, Ge Z et al. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun 2005 ; 73 : 912-920.
PubMed
24) Depis F, Kwon HK, Mathis D, Benoist C. Unstable FoxP3+ T regulatory cells in NZW mice. Proc Natl Acad Sci U S A 2016 ; 113 : 1345-1350.
PubMed
25) Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 1999 ; 156 : 837-841.
PubMed
26) Rohleder N. Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom Med 2014 ; 76 : 181-189.
PubMed
27) Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci 2010 ; 13 : 1161-1169.
PubMed
28) Hammack SE, Cooper MA, Lezak KR. Overlapping neurobiology of learned helplessness and conditioned defeat : Implications for PTSD and mood disorders. Neuropharmacology 2012 ; 62 : 565-575.
PubMed
29) Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF, Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007 ; 21 : 47-59.
PubMed
30) Johnson JD, Campisi J, Sharkey CM et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005 ; 135 : 1295-1307.
PubMed
31) Frank MG, Weber MD, Watkins LR, Maier SF. Stress-induced neuroinflammatory priming : A liability factor in the etiology of psychiatric disorders. Neurobiol Stress 2016 ; 4 : 62-70.
PubMed
32) Fonken LK, Frank MG, Gaudet AD, Maier SF. Stress and aging act through common mechanisms to elicit neuroinflammatory priming. Brain Behav Immun 2018 ; 73 : 148.
 
33) Wohleb ES, McKim DB, Shea DT et al. Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry 2014 ; 75 : 970-981.
 
34) Weber MD, Godbout JP, Sheridan JF. Repeated social defeat, neuroinflammation, and behavior : Monocytes carry the signal. Neuropsychopharmacology 2017 ; 42 : 46-61.
PubMed
35) Johnson JD, O'connor KA, Watkins LR, Maier SF. The role of IL-1beta in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience 2004 ; 127 : 569-577.
PubMed
36) Leemans JC, Cassel SL, Sutterwala FS. Sensing damage by the NLRP3 inflammasome. Immunol Rev 2011 ; 243 : 152-162.
PubMed
37) Iwata M, Ota KT, Li XY et al. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol Psychiatry 2016 ; 80 : 12-22.
PubMed
38) Weber MD, Frank MG, Tracey KJ, Watkins LR, Maier SF. Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats : A priming stimulus of microglia and the NLRP3 inflammasome. J Neurosci 2015 ; 35 : 316-324.
PubMed
39) Cheng Y, Pardo M, Armini RS et al. Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior. Brain Behav Immun 2016 ; 53 : 207-222.
PubMed
40) Lian YJ, Gong H, Wu TY et al. Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1. Brain Behav Immun 2017 ; 59 : 322-332.
PubMed
41) Fonken LK, Frank MG, D'Angelo HM et al. Mycobacterium vaccae immunization protects aged rats from surgery-elicited neuroinflammation and cognitive dysfunction. Neurobiol Aging 2018 ; 71 : 105-114.
PubMed
42) Frank MG, Fonken LK, Dolzani SD et al. Immunization with Mycobacterium vaccae induces an anti-inflammatory milieu in the CNS : Attenuation of stress-induced microglial priming, alarmins and anxiety-like behavior. Brain Behav Immun 2018 ; 73 : 352-363.
PubMed
43) Frank MG, Fonken LK, Watkins LR, Maier SF, Lowry CA. Could probiotics be used to mitigate neuroinflammation? ACS Chem Neurosci 2018 ; 10 : 13-15.
PubMed
44) Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008 ; 13 : 453-461.
PubMed
45) Hwang I, Yang J, Hong S et al. Non-transcriptional regulation of NLRP3 inflammasome signaling by IL-4. Immunol Cell Biol 2015 ; 93 : 591-599.
 
46) Zhao X, Wang H, Sun G, Zhang J, Edwards NJ, Aronowski J. Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci 2015 ; 35 : 11281-11291.
 
47) Ponomarev ED, Maresz K, Tan Y, Dittel BN. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 2007 ; 27 : 10714-10721.
PubMed
48) Hanisch UK. Microglia as a source and target of cytokines. Glia 2002 ; 40 : 140-155.
PubMed
49) Ransohoff RM. A polarizing question : Do M1 and M2 microglia exist? Nat Neurosci 2016 ; 19 : 987-991.
 
50) Cherry JD, Olschowka JA, O'Banion MK. Arginase 1+ microglia reduce Abeta plaque deposition during IL-1beta-dependent neuroinflammation. J Neuroinflammation 2015 ; 12 : 203.
PubMed
51) Lyons A, Downer EJ, Crotty S, Nolan YM, Mills KH, Lynch MA. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro : A role for IL-4. J Neurosci 2007 ; 27 : 8309-8313.
PubMed
52) Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue LF. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease : A potential mechanism leading to chronic inflammation. Exp Neurol 2009 ; 215 : 5-19.
PubMed
53) Bluthe RM, Lestage J, Rees G, Bristow A, Dantzer R. Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide-induced sickness behavior in rats. Neuropsychopharmacology 2002 ; 26 : 86-93.
PubMed
54) Park HJ, Shim HS, An K, Starkweather A, Kim KS, Shim I. IL-4 inhibits IL-1beta-induced depressive-like behavior and central neurotransmitter alterations. Mediators Inflamm 2015 ; 2015 : 941413.
PubMed
55) Alonso J, de JP, Lim CC et al. Association between mental disorders and subsequent adult onset asthma. J Psychiatr Res 2014 ; 59 : 179-188.
 
56) O'Donovan A, Cohen BE, Seal KH et al. Elevated risk for autoimmune disorders in Iraq and Afghanistan Veterans with posttraumatic stress disorder. Biol Psychiatry 2014 ; 77 : 365-374.
PubMed
57) Cohen M, Meir T, Klein E, Volpin G, Assaf M, Pollack S. Cytokine levels as potential biomarkers for predicting the development of posttraumatic stress symptoms in casualties of accidents. Int J Psychiatry Med 2011 ; 42 : 117-131.
PubMed
58) von KR, Hepp U, Kraemer B et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 2007 ; 41 : 744-752.
 
59) Newton TL, Fernandez-Botran R, Miller JJ, Burns VE. Interleukin-6 and soluble interleukin-6 receptor levels in posttraumatic stress disorder : Associations with lifetime diagnostic status and psychological context. Biol Psychol 2014 ; 99 : 150-159.
PubMed
60) Sommershof A, Aichinger H, Engler H et al. Substantial reduction of naive and regulatory T cells following traumatic stress. Brain Behav Immun 2009 ; 23 : 1117-1124.
PubMed
61) Zhou J, Nagarkatti P, Zhong Y et al. Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder. PLoS ONE 2014 ; 9 : e94075.
PubMed
62) Gola H, Engler H, Sommershof A et al. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry 2013 ; 13 : 40.
PubMed
63) Fox JH, Hassell JE, Jr., Siebler PH et al. Preimmunization with a heat-killed preparation of Mycobacterium vaccae enhances fear extinction in the fear-potentiated startle paradigm. Brain Behav Immun 2017 ; 66 : 70-84.
 

講演2. 腸管外現象に影響を及ぼす特定の乳酸菌

P.33 掲載の参考文献
1) Qin J, Li R, Raes J, et al : Nature 464 : 59-65
 
2) Kamada N, Seo SU, Chen GY, et al : Nat. Rev. Immunol. 13 : 321-335
 
3) Kau AL, Ahern PP, Griffin NW, et al : Nature 474 : 327-336
 
4) Nakamoto N, et al : Cell Rep 21 : 1215-1226, 2017.
PubMed
5) Hayashi A, Mikami Y, Miyamoto K, et al : Cell Reports 20 : 1513-1524
 

講演3. 口腔微生物叢と歯のケアが腸内微生物叢に及ぼす影響

P.40 掲載の参考文献
1) Johansson ME, Hansson GC. : Microbiology. Keeping bacteria at a distance. Science. 2011. 334 : 182-3
 
2) Nakajima M, Arimatsu K, Kato T, et al. : Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS One 2015. 10 : e0134234.
 
3) Ho MH, Chen CH, Goodwin JS, et al. Functional advantages of Porphyromonas gingivalis vesicles. PLoS One. 2015. 10 : e0123448.
PubMed
4) Guinane CM, Cotter PD. : Role of the gut microbiota in health and chronic gastrointestinal disease : understanding a hidden metabolic organ. Therap Adv Gastroenterol 2013. 6 : 295-308.
PubMed
5) Zakharzhevskaya NB, Vanyushkina AA, Altukhov IA, et al. Outer membrane vesicles secreted by pathogenic and nonpathogenic Bacteroides fragilis represent different metabolic activities. Sci Rep. 2017. 7 : 5008.
PubMed
6) Rainey K, Michalek SM, Wen ZT, et al. Glycosyltransferase-mediated biofilm matrix dynamics and virulence of Streptococcus mutans. Appl Environ Microbiol. 2019. 85 : e02247-18.
PubMed
7) Poole S, Singhrao SK, Kesavalu L, et al. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue. J Alzheimers Dis. 2013 ; 36 : 665-77.
 
8) Qian Jiang, Jia Liu, Liang Chen, et al. The oral microbiome in the elderly with dental caries and health. Front Cell Infect Microbiol. 2018 ; 8 : 442.
PubMed
9) Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS One. 2015 ; 10 : e0134234.
 
10) Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep. 2014 ; 4 : 4828.
PubMed
11) Olsen I, Amano A. Outer membrane vesicles-offensive weapons or good Samaritans? J Oral Microbiol. 2015 ; 7 : 27468.
PubMed
12) Atarashi K, Suda W, Luo C, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science. 2017 ; 358 : 359.
PubMed
13) Brito F, Zaltman C, Carvalho AT, et al. Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis. Eur J Gastroenterol Hepatol. 2013 ; 25 : 239.
PubMed
14) Szymanska S, Lordal M, Rathnayake N, et al. Dental caries, prevalence and risk factors in patients with Crohn's disease. PLoS One. 2014 ; 9 : e91059.
PubMed
15) Kojima A, Nakano K, Wada K, et al. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep. 2012 ; 2 : 332.
PubMed
16) 野村良太. Streptococcus mutansにおける新規コラーゲン 結合タンパクの同定と感染性心内膜炎に対する病原メカニズムの解析, 小児歯科学雑誌 2014 ; 52 : 1-11.
Medical*Online
17) Gur C, Ibrahim Y, Isaacson B, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015 ; 42 : 344-355.
PubMed
18) Komiya Y, Shimomura Y, Higurashi T, et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut. 2018 pii : gutjnl-2018-316661.
 
19) Johansson ME, Hansson GC. Microbiology. Keeping bacteria at a distance. Science. 2011 ; 334 : 182-3.
 
20) LeChevallier MW, Cawthon CD, Lee RG. Inactivation of biofilm bacteria. Appl Environ Microbiol. 1988 ; 54 : 2492.
PubMed
21) Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012 ; 10 : 717-25.
PubMed

講演4. ヒト腸内フローラの個体レベル研究と臨床研究 : 定量的フローラモニタリングの必要性

P.47 掲載の参考文献
Vandeputte D, Kathagen G, D'hoe K, Vieira-Silva S, Valles-Colomer M, Sabino J, Wang J, Tito RY, De Commer L, Darzi Y, Vermeire S, Falony G, Raes J. (2017). Quantitative microbiome profiling links gut community variation to microbial load. Nature. 551, 507-511
 
Vieira-Silva S*, Falony G*, Lima-Mendez G, Darzi Y, Garcia Yunta R, Okuda S, Vandeputte D, Hildebrand F, Chaffron S and Raes J. (2016) Species-function relationships shape ecological properties of the human gut microbiome. Nature Microbiology 1 : 16088
PubMed
Falony G*, Joossens M*, Vieira-Silva S*, Wang J*, Darzi Y, Faust K, Kurilshikov K, Bonder MJ, Valles-Colomer M, Vandeputte D, Titol RY, Chaffron S, Rymenans L. Verspecht C, De Sutter L, Lima-Mendez G, D' hoe K, Jonckheere K, Homola D, Garcia R, Tigchelaar EF, Eeckhaudt L, Fu JY, Henckaerts L, Zhernakova A, Wijnenga C and Raes J. (2016) Population-level analysis of gut microbiome variation. Science 352 : 560-4
 

講演5. 腸内フローラのdysbiosisとプロバイオティクス, シンバイオティクスの応用

P.57 掲載の参考文献
1) Woting A, Blaut M : The intestinal microbiota in metabolic disease. Nutrients 2016, 8 : 202.
PubMed
2) Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, Komiya K, Kawaguchi M, Shimizu T, Ogihara T, Tamura Y, Sakurai Y, Yamamoto R, Mita T, Fujitani Y, Fukuda H, Nomoto K, Takahashi T, Asahara T, Hirose T, Nagata S, Yamashiro Y, Watada H : Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabetes Care 2014, 37 : 2343-2350.
PubMed
3) Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K, Shibata A, Fujisawa Y, Minato T, Okamoto A, Ohno K, Hirayama M : Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease. PLoS One 2015, 10 : e0142164.
PubMed
4) Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, Ota M, Koga N, Hattori K, Kunugi H : Possible association of Bifidobacterium and Lactohacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 2016, 202 : 254-257.
PubMed
5) Matsuda K, Tsuji H, Asahara T, Kado Y, Nomoto K. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007, 73 : 32-9.
PubMed
6) Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K : Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 2009, 75 : 1961-9.
PubMed
7) Sakaguchi S, Saito M, Tsuji H, Asahara T, Takata O, Fujimura J, Nagata S, Nomoto K, Shimizu T : Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropenia. J Clin Microbiol 2010, 48 : 1624-8.
PubMed
8) Mizuno T, Yokoyama Y, Nishio H, Ebata T, Sugawara G, Asahara T, Nomoto K, Nagino M : Intraoperative bacterial translocation detected by bacterium-specific ribosomal RNA-targeted reverse-transcriptase polymerase chain reaction for the mesenteric lymph node strongly predicts postoperative infectious complications after major hepatectomy for biliary malignancies. Ann Surg 2010, 252 : 1013-9.
PubMed
9) Nishigaki E, Abe T, Yokoyama Y, Fukaya M, Asahara T, Nomoto K, Nagino M : The detection of intraoperative bacterial translocation in the mesenteric lymph nodes is useful in predicting patients at high risk for postoperative infectious complications after esophagectomy. Ann Surg 2014, 259 : 477-84.
PubMed
10) Fuller R. Probiotics in man and animals. J Appl Bacteriol 66 : 365-78, 1989.
PubMed
11) Gibson GR, Roberfroid MB : Dietary modulation of the human colonic microbiota : introducing the concept of prebiotics. J Nutr 1995, 125 : 1401-12.
PubMed
12) Schrezenmeir J, de Vrese M : Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 2001, 73 : 361S-4S.
PubMed
13) Komatsu S, Yokoyama Y, Nagino M : Gut microbiota and bacterial translocation in digestive surgery : the impact of probiotics. Langenbecks Arch Surg 2017, 402 : 401-16.
PubMed
14) Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R : Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57 : 1470-81.
PubMed
15) 金澤昭雄 : 2型糖尿病と腸内フローラ-プロバイオティクスによる介入の効果-. J・JSMUFF 2018, 12 : 24-8.
 
16) Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, Komiya K, Kawaguchi M, Shimizu T, Ogihara T, Tamura Y, Sakurai Y, Yamamoto R, Mita T, Fujitani Y, Fukuda H, Nomoto K, Takahashi T, Asahara T, Hirose T, Nagata S, Yamashiro Y, Watada H : Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabetes Care 2014, 37 : 2343-50.
PubMed
17) Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y. Synbiotics reduce postoperative infectious complications : a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005, 390 : 104-13.
PubMed
18) Hayakawa M, Asahara T, Henzan N, Murakami H, Yamamoto H, Mukai N, Minami Y, Sugano M, Kubota N, Uegaki S, Kamoshida H, Sawamura A, Nomoto K, Gando S : Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci 2011, 56 : 2361-5.
PubMed
19) Shimizu K, Ogura H, Hamasaki T, Goto M, Tasaki O, Asahara T, Nomoto K, Morotomi M, Matsushima A, Kuwagata Y, Sugimoto H : Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci 2011, 56 : 1171-7.
PubMed
20) Suzuki Y, Ikeda K, Sakuma K, Kawai S, Sawaki K, Asahara T, Takahashi T, Tsuji H, Nomoto K, Nagpal R, Wang C, Nagata S, Yamashiro Y : Association between yogurt consumption and intestinal microbiota in healthy young adults differs by host gender. Front Microbiol 2017, 11 ; 8 : 847.
 
21) Ostling CE, Lindgren SE : Inhibition of enterobacteria and Listeria growth by lactic, acetic and formic acids. J Appl Bacteriol 1993, 75 : 18-24.
PubMed
22) Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ : Colonic health : fermentation and short chain fatty acids. J Clin Gastroenterol 2006, 40 : 235-43.
PubMed
23) Kamath PS, Phillips SF, Zinsmeister AR : Short-chain fatty acids stimulate ileal motility in humans. Gastroenterology 1988, 95 : 1496-502.
PubMed
24) Asahara T, Takahashi A, Yuki N, Kaji R, Takahashi T, Nomoto K : Protective Effect of a synbiotic against multidrug-resistant Acinetobacter baumannii in a murine infection model. Antimicrob Agents Chemother 2016, 60 : 3041-50.
 
25) Yokoyama Y, Mizuno T, Sugawara G, Asahara T, Nomoto K, Igami T, Ebata T, Nagino M : Profile of preoperative fecal organic acids closely predicts the incidence of postoperative infectious complications after major hepatectomy with extrahepatic bile duct resection : Importance of fecal acetic acid plus butyric acid minus lactic acid gap. Surgery 2017, 162 : 928-36.
PubMed
26) Berg RD, Garlington AW : Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979, 23 : 403-11.
 
27) Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM : Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol 2014, 14 : 189.
PubMed
28) Sato J, Kanazawa A, Azuma K, Ikeda F, Goto H, Komiya K, Kanno R, Tamura Y, Asahara T, Takahashi T, Nomoto K, Yamashiro Y, Watada H : Probiotic reduces bacterial translocation in type 2 diabetes mellitus : A randomised controlled study. Sci Rep 2017, 7 : 12115.
PubMed
29) Tsujimoto H, Morimoto Y, Takahata R, Nomura S, Yoshida K, Hiraki S, Horiguchi H, Miyazaki H, Ono S, Saito D, Hara I, Ozeki E, Yamamoto J, Hase K : Theranostic photosensitive nanoparticles for lymph node metastasis of gastric cancer. Ann Surg Oncol 2015, 22 : S923-8.
PubMed
30) Polakowski CB, Kato M, Preti VB, Schieferdecker MEM, Ligocki Campos AC : Impact of the preoperative use of synbiotics in colorectal cancer patients : A prospective, randomized, double-blind, placebo-controlled study. Nutrition 2019, 58 : 40-6.
PubMed
31) Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Ohue M, Ohigashi H, Asahara T, Nomoto K, Ishikawa O : Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy : a prospective randomized controlled trial. Surgery 2012, 152 : 832-42.
PubMed
32) Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, Bengmark S, Neuhaus P : Early enteral supply of lactobacillus and fiber versus selective bowel decontamination : a controlled trial in liver transplant recipients. Transplantation 2002, 74 : 123-27.
PubMed
33) Anderson AD, McNaught CE, Jain PK, MacFie J : Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004, 53 : 241-5.
PubMed
34) Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P : Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial. Am J Transplant 2005, 5 : 125-30.
PubMed
35) Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, Nomoto K, Nimura Y. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery : a randomized controlled trial. Ann Surg 2006, 244 : 706-14.
PubMed
36) Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nussler NC, Bengmark S, Neuhaus P : Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy : a randomized, double-blind trial. Ann Surg 2007, 246 : 36-41.
PubMed
37) Reddy BS, Macfie J, Gatt M, Larsen CN, Jensen SS, Leser TD : Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 2007, 94 : 546-54.
PubMed
38) Horvat M, Krebs B, Potrc S, Ivanecz A, Kompan L : Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wien Klin Wochenschr 2010, 122, Suppl 2 : 26-30.
 
39) Eguchi S, Takatsuki M, Hidaka M, Soyama A, Ichikawa T, Kanematsu T : Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation : a prospective randomized study. Am J Surg 2011, 201 : 498-502.
PubMed
40) Usami M, Miyoshi M, Kanbara Y, Aoyama M, Sakaki H, Shuno K, Hirata K, Takahashi M, Ueno K, Tabata S, Asahara T, Nomoto K : Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. JPEN J Parenter Enteral Nutr 2011, 35 : 317-28.
PubMed
41) Rayes N, Pilarski T, Stockmann M, Bengmark S, Neuhaus P, Seehofer D : Effect of pre- and probiotics on liver regeneration after resection : a randomised, double-blind pilot study. Benef Microbes 2012, 3 : 237-44.
PubMed
42) Okazaki M, Matsukuma S, Suto R, Miyazaki K Hidaka M, Matsuo M, Noshima S, Zempo N, Asahara T, Nomoto K : Perioperative synbiotic therapy in elderly patients undergoing gastroenterological surgery : a prospective, randomized control trial. Nutrition 2013, 29 : 1224-30.
PubMed
43) Yokoyama Y, Nishigaki E, Abe T, Fukaya M, Asahara T, Nomoto K, Nagino M : Randomized clinical trial of the effect of perioperative synbiotics versus no synbiotics on bacterial translocation after oesophagectomy. Br J Surg 2014, 101 : 189-99.
PubMed
44) Rammohan A, Sathyanesan J, Rajendran K, Pitchaimuthu A, Perumal SK, Balaraman K, Ramasamy R, Palaniappan R, Govindan M : Synbiotics in surgery for chronic pancreatitis : are they truly effective? A single-blind prospective randomized control trial. Ann Surg 2015, 262 : 31-7.
 
45) Komatsu S, Sakamoto E, Norimizu S, Shingu Y, Asahara T, Nomoto K, Nagino M : Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery : a randomized controlled trial. Surg Today 2016, 46 : 479-90.
PubMed
46) Yokoyama Y, Miyake T, Kokuryo T, Asahara T, Nomoto K, Nagino M : Effect of perioperative synbiotic treatment on bacterial translocation and postoperative infectious complications after pancreatoduodenectomy. Dig Surg 2016, 33 : 220-9.
PubMed
47) Pitsouni E, Alexiou V, Saridakis V, Peppas G, Falagas ME : Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2009, 65 : 561-70.
PubMed
48) Wu XD, Liu MM, Liang X, Hu N, Huang W : Effects of perioperative supplementation with pro-/synbiotics on clinical outcomes in surgical patients : A meta-analysis with trial sequential analysis of randomized controlled trials. Clin Nutr 2018, 37 : 505-15.
PubMed
49) Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Matsushima A, Tasaki O, Fujita K, Hosotsubo H, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H : Synbiotics decrease the incidence of septic complications in patients with severe SIRS : a preliminary report. Dig Dis Sci 2009, 54 : 1071-8.
PubMed
50) Motoori M, Yano M, Miyata H, Sugimura K, Saito T, Omori T, Fujiwara Y, Miyoshi N, Akita H, Gotoh K, Takahashi H, Kobayashi S, Noura S, Ohue M, Asahara T, Nomoto K, Ishikawa O, Sakon M : Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients. Clin Nutr 2017, 36 : 93-9.
PubMed
51) Peleg AY, Seifert H, Paterson DL : Acinetobacter baumannii : emergence of a successful pathogen. Clin Microbiol Rev 2008, 21 : 538-82.
PubMed

書評

最近チェックした商品履歴

Loading...